Related Experiment Video
Updated: May 13, 2026
07:44
Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture
Published on: June 23, 2020
In vitro three-dimensional tumor microenvironment models for anticancer drug discovery
Keiran Sm Smalley1, Mercedes Lioni, Kazuhiro Noma
1The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA +1 215 898 0002 ; ksmalley@wistar.org.
Expert Opinion on Drug Discovery
|March 14, 2013
Summary
Preclinical cancer models often fail to predict drug effectiveness. Three-dimensional cell cultures accurately mimic the tumor microenvironment, improving anticancer drug discovery and leading to more relevant experimental results.
Area of Science:
- Oncology
- Biotechnology
- Drug Discovery
Background:
- Preclinical models for anticancer drug discovery have historically shown poor predictivity.
- The tumor microenvironment (TME) is increasingly recognized as a key factor influencing cancer cell response to therapies.
- Recent advancements have enhanced understanding of how the 3D microenvironment affects tumor cell signaling.
Purpose of the Study:
- To review the benefits of three-dimensional (3D) in vitro cell culture models in cancer drug discovery.
- To highlight how 3D models improve the accuracy of tumor microenvironment simulation.
- To emphasize the potential for more physiologically relevant experimental outcomes in drug development.
Main Methods:
- Review of recent scientific literature on 3D cell culture and cancer models.
- Analysis of how the tumor microenvironment influences therapeutic response.
- Discussion of the advantages of 3D in vitro models over traditional 2D cultures.
Main Results:
- 3D cell culture models offer a more accurate representation of the in vivo tumor microenvironment.
- These models can reveal drug responses that are missed in 2D cultures.
- Improved understanding of microenvironment-mediated signaling pathways is achieved.
Conclusions:
- Three-dimensional in vitro models are crucial for advancing anticancer drug discovery.
- Accurate modeling of the tumor microenvironment enhances the predictivity of preclinical studies.
- Adoption of 3D models can lead to more effective and targeted cancer therapies.
